Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Safety Evaluation of Edoxaban in Elderly Patients With Frailty Criteria
Authors not listed
Galaxia Empírica · 2023
Abstract
The aim of the present study is to prospectively evaluate the safety of Edoxaban.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-07-02 MST
Cite this
APA
Anonymous. (2023). Safety Evaluation of Edoxaban in Elderly Patients With Frailty Criteria. <em>Galaxia Empírica</em>. https://clinicaltrials.gov/study/NCT05732506
Vancouver
Anonymous. Safety Evaluation of Edoxaban in Elderly Patients With Frailty Criteria. Galaxia Empírica. 2023.
BibTeX
@misc{anon2023Safety,
title = {Safety Evaluation of Edoxaban in Elderly Patients With Frailty Criteria},
author = {Anonymous},
journal = {Galaxia Empírica},
year = {2023},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Centre Hospitalier Saint Joseph Saint Luc de Lyon 2019
Open access · US-GOV
ZEBinix Retention Rate in Epilepsy in Elderly Patients
Istituto Oncologico Veneto IRCCS 2019
Open access · US-GOV
Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma: Observational Study
University of Padova 2018
Open access · US-GOV
Edoxaban Performance in Senior Citizen With Non-valvular Atrial Fibrillation Evaluated Per Frailty
The First Affiliated Hospital with Nanjing Medical University 2012
Open access · US-GOV
A Prospective, Single-arm, Open-label, Phase 2 Study to Evaluate Efficacy and Safety of R-GemOx Regimen as First-line Treatment in Elderly Patients With Diffuse Large B-cell Lymphoma (DLBCL).
Novartis Vaccines 2010
Open access · US-GOV
Open-label, Uncontrolled Postmarketing Study to Evaluate Immunogenicity, Safety and Tolerability of Cell-derived A/H1N1 Influenza HA Vaccine in Healthy Japanese Elderly Subjects
Longeveron Inc. 2014
Open access · US-GOV